Last reviewed · How we verify
NCT05613244: TFS-ORB
Descriptive Study of a Cohort of Orbital Solitary Fibrous Tumors
trial testing Phone call in Orbital Tumor in 10 participants. Completed in 25 July 2023.
25 July 2023
Quick facts
| Lead sponsor | Fondation Ophtalmologique Adolphe de Rothschild |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 26 January 2023 |
| Primary completion | 25 July 2023 |
| Estimated completion | 25 July 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Phone call
Conditions studied
- Orbital Tumor — all drugs for Orbital Tumor →
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild — full company profile →
Who can join
Adults 18 to 120, any sex, with Orbital Tumor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Orbital solitary fibrous tumors are rare tumors with an intermediate potential of malignancy. Orbital solitary fibrous tumors' prognostic criteria are still poorly understood. Some patients with orbital solitary fibrous tumors have been treated at the Adolphe de Rothschild Foundation Hospital. This cohort will be studied to describe the recurrence rate and to identify predictive factors of recurrence or metastasis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05613244
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Phone call
Trials testing the same drug.
- NCT06805383 — Randomized Trial of Follow-up to Mailed FIT Kits · NA · completed
- NCT06079229 — Quality of Life in Elderly Patients After Pancreatic Cancer Surgery · completed
- NCT05964842 — Using SMS Reminders, Phone Calls and Money Incentives to Enhance Linkage to Care of Presumptive TB Patients in Uganda · NA · completed
- NCT06046807 — Long-Term Post Thrombotic Syndrome Assessment (CELEST Long Term). · unknown
- NCT05910229 — Telephone Paramedical Support Prior to the Radiotherapy Simulation Scanner for Patients with Prostate Cancer · NA · completed
Other Fondation Ophtalmologique Adolphe de Rothschild trials
Trials by the same sponsor.
- NCT04701619 — Immuno-inflammatory Profile and Response to Ischemic Stroke Reperfusion Therapies (IMMUNOSTROKE) · NA · not yet recruiting
- NCT04763161 — Immuno-inflammation in the Acute Phase of an Ischaemic Cerebral Accident Managed by Decompressive Hemicraniectomy: a Cas · not yet recruiting
- NCT06264531 — Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous M · Phase 2, PHASE3 · recruiting
- NCT06895044 — Evolution of Ocular Growth in Myopic Children: A Prospective Cohort Study · recruiting
- NCT06644196 — Creation of a Database of Images of the Eye With the Holographic Doppler Laser · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05613244 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondation Ophtalmologique Adolphe de Rothschild
- Last refreshed: 23 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05613244.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing